Tingbo Liang Selected Research

Tingbo Liang Research Topics

Disease

74	Neoplasms (Cancer) 02/2023 - 05/2013
31	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 12/2014
25	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 07/2007
14	Adenocarcinoma 02/2023 - 09/2015
14	COVID-19 01/2022 - 01/2020
10	Hypoxia (Hypoxemia) 02/2023 - 05/2013
10	Carcinogenesis 01/2022 - 02/2013
8	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2016
6	Liver Neoplasms (Liver Cancer) 12/2020 - 08/2019
5	Infections 01/2022 - 01/2016
5	Inflammation (Inflammations) 01/2021 - 03/2016
5	Pancreatic Fistula (Pancreatic Fistulas) 01/2020 - 01/2016
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 03/2009
4	Pneumonia (Pneumonitis) 01/2022 - 01/2020
4	Liver Diseases (Liver Disease) 01/2020 - 02/2002
3	Fibrosis (Cirrhosis) 02/2023 - 11/2016
3	Hemorrhage 01/2020 - 01/2005
3	Reinfection 02/2006 - 02/2002
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2013
2	Wounds and Injuries (Trauma) 01/2021 - 03/2010
2	Death (Near-Death Experience) 09/2020 - 10/2014
2	Critical Illness (Critically Ill) 01/2020 - 01/2020
2	Rheumatoid Arthritis 01/2020 - 06/2016
2	Circulating Neoplastic Cells 01/2019 - 06/2018
2	Disease Progression 10/2018 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

10	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2020
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2014
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2014
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2016
6	AntigensIBA 02/2022 - 07/2014
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
5	Gemcitabine FDA Link 02/2022 - 09/2015
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2002
4	Oxygen (Dioxygen)IBA 02/2023 - 12/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2002
4	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2016
4	Proto-Oncogene Proteins c-metIBA 12/2020 - 01/2020
4	OSI 027IBA 10/2020 - 09/2015
4	folfirinoxIBA 01/2019 - 04/2016
3	Peptides (Polypeptides)IBA 02/2022 - 01/2019
3	Therapeutic UsesIBA 02/2022 - 09/2015
3	LigandsIBA 02/2022 - 11/2021
3	EnzymesIBA 01/2022 - 01/2020
3	InterferonsIBA 01/2022 - 01/2014
3	CytokinesIBA 01/2022 - 02/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2016
3	Biological ProductsIBA 01/2022 - 02/2015
3	CateninsIBA 01/2017 - 05/2013
3	Lamivudine (Epivir)FDA Link 02/2006 - 02/2002
2	Capsules (Microcapsules)IBA 02/2023 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 02/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 11/2021
2	CalcineurinIBA 01/2022 - 01/2021
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2022
2	Neutralizing AntibodiesIBA 11/2021 - 01/2020
2	Cadherins (E-Cadherin)IBA 11/2021 - 01/2016
2	AcidsIBA 02/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 02/2021 - 01/2020
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
2	mRNA VaccinesIBA 01/2021 - 01/2021
2	Cancer VaccinesIBA 01/2021 - 01/2020
2	SolutionsIBA 01/2021 - 03/2010
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2019
2	Protons (Proton)IBA 12/2020 - 10/2016
2	polycationsIBA 12/2020 - 10/2016
2	Adenosine Triphosphate (ATP)IBA 12/2020 - 01/2020
2	Adenosine Triphosphatases (ATPase)IBA 12/2020 - 01/2020
2	Nucleic AcidsIBA 12/2020 - 05/2020
2	Sirolimus (Rapamycin)FDA Link 12/2020 - 03/2010
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2020 - 01/2020
2	Polymethyl Methacrylate (Sol)IBA 11/2020 - 03/2016
2	Viral RNAIBA 10/2020 - 01/2020
2	dicarboxydine (DCD)IBA 09/2020 - 01/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2019
2	Piwi-Interacting RNAIBA 01/2020 - 01/2020
2	Ritonavir (Norvir)FDA Link 01/2020 - 01/2020
2	ProcalcitoninIBA 01/2020 - 10/2018
2	CarbohydratesIBA 01/2020 - 07/2014
2	Lopinavir FDA Link 01/2020 - 01/2020
2	Anaphase-Promoting Complex-CyclosomeIBA 01/2020 - 01/2020
2	Circulating Tumor DNAIBA 01/2020 - 06/2018
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2019
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 01/2017
2	VimentinIBA 01/2019 - 01/2016
2	degrasynIBA 11/2018 - 06/2015
2	Small Interfering RNA (siRNA)IBA 01/2016 - 05/2013

Therapy/Procedure

34	Therapeutics 04/2022 - 02/2006
19	Immunotherapy 02/2023 - 01/2014
18	Liver Transplantation 01/2022 - 02/2002
14	Drug Therapy (Chemotherapy) 01/2022 - 12/2014
6	Pancreaticoduodenectomy 01/2020 - 01/2016
4	Lung Transplantation 01/2022 - 01/2020
3	Neoadjuvant Therapy 01/2020 - 07/2017
2	Oncolytic Virotherapy 11/2020 - 01/2020
2	Warm Ischemia 09/2020 - 08/2008
2	Length of Stay 01/2020 - 01/2018
2	Ligation 01/2020 - 01/2005